(NYSE: NVRO) Nevro's forecast annual revenue growth rate of 2.74% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.49%.
Nevro's revenue in 2023 is $422,842,000.On average, 8 Wall Street analysts forecast NVRO's revenue for 2023 to be $15,148,922,190, with the lowest NVRO revenue forecast at $15,114,345,943, and the highest NVRO revenue forecast at $15,210,326,710. On average, 8 Wall Street analysts forecast NVRO's revenue for 2024 to be $15,996,637,650, with the lowest NVRO revenue forecast at $15,648,014,939, and the highest NVRO revenue forecast at $16,745,150,054.
In 2025, NVRO is forecast to generate $17,357,203,947 in revenue, with the lowest revenue forecast at $16,810,211,329 and the highest revenue forecast at $18,557,886,778.